Innovation
4 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace active.
| Year | Filings |
|---|---|
| 2025 | 1 |
| 2026 | 3 |
Investor mix
6 investors on record; lead investors include Saisei Ventures, Alaska Permanent Fund, Cure Ventures, The Column Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Angel & family office | 1 | 17% |
| Other / undisclosed | 2 | 33% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
8 Aug 2025 · VP, Clinical Operations · San Diego
Based on job postings tracked across public sources.